Citation: Mm. Ali et al., Analysis of failure time hierarchical data in the presence of competing risks with application to oral contraceptive pill use in Egypt, STAT MED, 20(23), 2001, pp. 3611-3624
Authors:
Babiker, AG
Darbyshire, JH
Cooper, DA
Hooker, MH
Withnall, R
Yeni, P
Citation: Ag. Babiker et al., An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: Design, rationale, and methodsof the initio trial, CONTR CL TR, 22(2), 2001, pp. 160-175
Authors:
Clarke, JR
Kaye, S
Babiker, AG
Hooker, MH
Tedder, R
Weber, JN
Citation: Jr. Clarke et al., Comparison of a point mutation assay with a line probe assay for the detection of the major mutations in the HIV-1 reverse transcriptase gene associated with reduced susceptibility to nucleoside analogues, J VIROL MET, 88(2), 2000, pp. 117-124
Authors:
Churchill, DR
Pym, AS
Galpin, S
Foxall, R
Stainsby, C
Clarke, JR
Kaye, S
Bloor, S
Larder, BA
Wills, B
Sun, E
Babiker, AG
Back, DJ
Weber, JN
Citation: Dr. Churchill et al., The rabbit study: Ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patients, AIDS RES H, 15(13), 1999, pp. 1181-1189
Authors:
Easterbrook, PJ
Goodall, RL
Babiker, AG
Yu, LM
Smith, D
Cooper, DA
Gazzard, BG
Citation: Pj. Easterbrook et al., Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?, J ANTIMICRO, 43(3), 1999, pp. 379-388
Authors:
White, IR
Babiker, AG
Walker, S
Darbyshire, JH
Citation: Ir. White et al., Randomization-based methods for correcting for treatment changes: Examplesfrom the Concorde trial, STAT MED, 18(19), 1999, pp. 2617-2634
Authors:
Touloumi, G
Pocock, SJ
Babiker, AG
Darbyshire, JH
Citation: G. Touloumi et al., Estimation and comparison of rates of change in longitudinal studies with informative drop-outs, STAT MED, 18(10), 1999, pp. 1215-1233
Authors:
Aboulker, JP
Babiker, AG
Flandre, P
Gazzard, B
Loveday, C
Nunn, AJ
Goudsmit, J
Huraux, JM
van der Noorda, J
Weiss, R
Boucher, C
Schurrman, R
Brun-Vezinet, F
Descamps, D
Jeffries, D
Tedder, R
Weber, J
Darbyshire, JH
Reiss, P
Weverling, G
Citation: Jp. Aboulker et al., An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome, AIDS, 13(5), 1999, pp. 565-573
Authors:
Babiker, AG
Darbyshire, JH
Gazzard, BG
Hooker, MH
Kitchen, V
Newberry, A
Peto, TE
Tedder, R
Weber, J
Breckenridge, A
Back, D
Blatchford, N
Gartland, M
Jeffries, D
Johnson, M
Plummer, K
Wills, B
Loveday, C
Weller, IVD
Withnall, R
Citation: Ag. Babiker et al., A randomized trial comparing regimens of four reverse transcriptase inhibitors given together or cyclically in HIV-1 infection - The Quattro Trial, AIDS, 13(16), 1999, pp. 2209-2217
Authors:
Aboulker, JP
Babiker, AG
Brun-Vezinet, F
Darbyshire, JH
Flandre, P
Gazzard, B
Nunn, AJ
Goodall, R
Aber, V
Bragman, K
Breckenridge, AM
Carbon, C
Charreau, I
Chene, G
Collis, P
Cooper, D
Dormont, J
Fiddian, P
Flepp, M
Goebel, FD
Hooker, M
Lange, J
Luthy, R
Peto, TEA
Reiss, P
Seligmann, M
Stone, AB
Thomis, J
Vella, S
Walckenaer, G
Warrell, D
Weller, IVD
Wilber, R
Yeni, P
Yeo, J
Withnall, R
Goudsmit, J
Huraux, JM
van der Noorda, J
Weiss, R
Boucher, C
Schuurman, R
Descamps, D
Jeffries, D
Tedder, R
Weber, J
Krzyanowski, C
Weverling, G
Citation: Jp. Aboulker et al., HIV-1 RNA response to antiretroviral treatment in 1280 participants in theDelta Trial: an extended virology study, AIDS, 13(1), 1999, pp. 57-65